Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04892446
Title Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.